BUY Dr. Lal Path Labs Ltd. — Siddharth Rai Mangala
bySiddharth Rai MangalaHorizon: NA (inferred Intraday)24 Sept 2026, 2:28 pm ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·24 Sept · today
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dr. Lal Path Labs
- BUY — Amit Seth9 Nov 2026 · Same day · target ₹2,120 · Expired
- BUY — Sudeep Shah, SBICAP Securities9 Nov 2026 · ~2 weeks · target ₹2,150 · Active
- BUY — Shrikant Chouhan, Kotak Securities5 Nov 2026 · ~2 weeks · target ₹2,150 · SL hit
- SELL — Citigroup5 Nov 2026 · ~1 year · target ₹1,750 · Active
- BUY — Citigroup5 Nov 2026 · ~1 year · target ₹2,380 · Active
More from Siddharth Rai Mangala
- BUY Anand Rathi Wealth13 Nov 2026 · ~1 year · target ₹2,440 · Active
- BUY FSN E-Commerce Ventures13 Nov 2026 · ~2 weeks · target ₹385 · Active
- BUY Premier Energies13 Nov 2026 · ~1 year · target ₹930 · Active
- BUY Max Healthcare Institute13 Nov 2026 · ~2 weeks · target ₹975 · Active
- BUY V2 Retail12 Nov 2026 · ~1 year · target ₹280 · Active

